SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-210626
Filing Date
2020-08-05
Accepted
2020-08-05 16:04:25
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d198847d10q.htm   iXBRL 10-Q 1984773
2 EX-10.1 d198847dex101.htm EX-10.1 115367
3 EX-10.2 d198847dex102.htm EX-10.2 31968
4 EX-31.1 d198847dex311.htm EX-31.1 10810
5 EX-31.2 d198847dex312.htm EX-31.2 10788
6 EX-32.1 d198847dex321.htm EX-32.1 5932
  Complete submission text file 0001193125-20-210626.txt   6966690

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA gbt-20200630.xsd EX-101.SCH 38073
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20200630_cal.xml EX-101.CAL 43532
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20200630_def.xml EX-101.DEF 182392
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20200630_lab.xml EX-101.LAB 374682
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20200630_pre.xml EX-101.PRE 303547
12 EXTRACTED XBRL INSTANCE DOCUMENT d198847d10q_htm.xml XML 1137892
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 201077196
SIC: 2834 Pharmaceutical Preparations